The objective of this study was to create a 5-year survivorship model to identify key clinical features of cystic fibrosis. Such a model could help researchers and clinicians to evaluate therapies, improve the design of prospective studies, monitor practice patterns, counsel individual patients, and determine the best candidates for lung transplantation. The authors used information from the Cystic Fibrosis Foundation Patient Registry (CFFPR), which has collected longitudinal data on approximately 90% of cystic fibrosis patients diagnosed in the United States since 1986. They developed multivariate logistic regression models by using data on 5,820 patients randomly selected from 11,630 in the CFFPR in 1993. Models were tested for goodness of fit and were validated for the remaining 5,810 patients for 1993. The validated 5-year survivorship model included age, forced expiratory volume in 1 second as a percentage of predicted normal, gender, weight-for-age z score, pancreatic sufficiency, diabetes mellitus, Staphylococcus aureus infection, Burkerholderia cepacia infection, and annual number of acute pulmonary exacerbations. The model provides insights into the complex nature of cystic fibrosis and supplies a rigorous tool for clinical practice and research.Keywords cystic fibrosis; logistic models; models, theoretical; multivariate analysis; proportional hazards models; survival analysis Cystic fibrosis is an autosomal recessive, multisystem disease leading to significant morbidity and early death. Since the disease was described in 1938 (1,2), treatments for its pancreatic and pulmonary manifestations have improved median survival in the United States from less than 6 months to about 32 years in 1998 (3). Severe pulmonary disease is the primary cause of cystic-fibrosis-related mortality, constituting 76.4 percent of such deaths in 1998 (3). Chronic inflammation and infection of the airways characterize cystic-fibrosis-related (4,5). Malnutrition, in part due to pancreatic insufficiency, was the major feature of the disease according to early reports, and it continues to be a substantial problem (1-3). With improved survival, additional manifestations such as diabetes mellitus have been recognized (6,7).Many studies have considered the survival effect of a variety of clinical and physiologic features of cystic fibrosis such as forced expiratory volume in 1 second as a percentage of predicted normal (FEV 1 %), gender, age, pregnancy, or particular therapies (4-26). We developed a single survivorship model that integrated many characteristics of cystic fibrosis and quantified the relative contribution of each.The current most commonly used survival model of cystic fibrosis was developed in 1992 and is based on FEV 1 % alone or on age, gender, and FEV 1 % (15). Clinicians often use this model to select patients to refer for lung transplantation. The model is relatively simple to use for estimating cystic fibrosis survival, but it has not been validated and does not incorporate clinical features of cystic fib...
The optimal water transport system in plants should maximize hydraulic conductance (which is proportional to photosynthesis) for a given investment in transport tissue. To investigate how this optimum may be achieved, we have performed computer simulations of the hydraulic conductance of a branched transport system. Here we show that the optimum network is not achieved by the commonly assumed pipe model of plant form, or its antecedent, da Vinci's rule. In these representations, the number and area of xylem conduits is constant at every branch rank. Instead, the optimum network has a minimum number of wide conduits at the base that feed an increasing number of narrower conduits distally. This follows from the application of Murray's law, which predicts the optimal taper of blood vessels in the cardiovascular system. Our measurements of plant xylem indicate that these conduits conform to the Murray's law optimum as long as they do not function additionally as supports for the plant body.
A large array of species distribution model (SDM) approaches has been developed for explaining and predicting the occurrences of individual species or species assemblages. Given the wealth of existing models, it is unclear which models perform best for interpolation or extrapolation of existing data sets, particularly when one is concerned with species assemblages. We compared the predictive performance of 33 variants of 15 widely applied and recently emerged SDMs in the context of multispecies data, including both joint SDMs that model multiple species together, and stacked SDMs that model each species individually combining the predictions afterward. We offer a comprehensive evaluation of these SDM approaches by examining their performance in predicting withheld empirical validation data of different sizes representing five different taxonomic groups, and for prediction tasks related to both interpolation and extrapolation. We measure predictive performance by 12 measures of accuracy, discrimination power, calibration, and precision of predictions, for the biological levels of species occurrence, species richness, and community composition. Our results show large variation among the models in their predictive performance, especially for communities comprising many species that are rare. The results do not reveal any major trade‐offs among measures of model performance; the same models performed generally well in terms of accuracy, discrimination, and calibration, and for the biological levels of individual species, species richness, and community composition. In contrast, the models that gave the most precise predictions were not well calibrated, suggesting that poorly performing models can make overconfident predictions. However, none of the models performed well for all prediction tasks. As a general strategy, we therefore propose that researchers fit a small set of models showing complementary performance, and then apply a cross‐validation procedure involving separate data to establish which of these models performs best for the goal of the study.
Secondary bacterial infections are a leading cause of illness and death during epidemic and pandemic influenza. Experimental studies suggest a lethal synergism between influenza and certain bacteria, particularly Streptococcus pneumoniae, but the precise processes involved are unclear. To address the mechanisms and determine the influences of pathogen dose and strain on disease, we infected groups of mice with either the H1N1 subtype influenza A virus A/Puerto Rico/8/34 (PR8) or a version expressing the 1918 PB1-F2 protein (PR8-PB1-F2(1918)), followed seven days later with one of two S. pneumoniae strains, type 2 D39 or type 3 A66.1. We determined that, following bacterial infection, viral titers initially rebound and then decline slowly. Bacterial titers rapidly rise to high levels and remain elevated. We used a kinetic model to explore the coupled interactions and study the dominant controlling mechanisms. We hypothesize that viral titers rebound in the presence of bacteria due to enhanced viral release from infected cells, and that bacterial titers increase due to alveolar macrophage impairment. Dynamics are affected by initial bacterial dose but not by the expression of the influenza 1918 PB1-F2 protein. Our model provides a framework to investigate pathogen interaction during coinfections and to uncover dynamical differences based on inoculum size and strain.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.